The adverse effects on fetal development of alcohol, tobacco and other substances such as psychostimulants and opioids are well known. Women who are pregnant or who may become pregnant are therefore a high priority for interventions to reduce substance use.

These clinical guidelines are intended to support a range of health care workers who care for pregnant and breastfeeding women with substance use issues, and their infants and families. The guidelines are based on the best currently available evidence, developed through a rigorous process in which international and Australian research literature was reviewed by experts and consensus achieved.

Related link

Summary Document - Clinical Guidelines for the Management of Substance Use During Pregnancy, Birth and the Postnatal Period

File Size: 1389 kb
Type: Guideline
Date of Publication: 01 October 2014